Mathematical analysis and drug exposure evaluation of pharmacokinetic models with endogenous production and simultaneous first-order and Michaelis-Menten elimination: the case of single dose

被引:6
作者
Wu, Xiaotian [1 ,2 ]
Nekka, Fahima [2 ,3 ]
Li, Jun [2 ,3 ]
机构
[1] Shanghai Maritime Univ, Dept Math, Shanghai 201306, Peoples R China
[2] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Pharmacokinetic model; X function; Endogenous production; Simultaneous first-order and Michaelis-Menten elimination; Area under the concentration time curve (AUC); RECOMBINANT-HUMAN-ERYTHROPOIETIN; G-CSF; NEUTROPHIL PRODUCTION; CANCER-PATIENTS; KINETICS; CHEMOTHERAPY; DISPOSITION; EQUATION; RATS;
D O I
10.1007/s10928-018-9599-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drugs with an additional endogenous source often exhibit simultaneous first-order and Michaelis-Menten elimination and are becoming quite common in pharmacokinetic modeling. In this paper, we investigate the case of single dose intravenous bolus administration for the one-compartment model. Relying on a formerly introduced transcendent function, we were able to analytically express the concentration time course of this model and provide the pharmacokinetic interpretation of its components. Using the concept of the corrected concentration, the mathematical expressions for the partial and total areas under the concentration time curve (AUC) were also given. The impact on the corrected concentration and AUC is discussed as well as the relative contribution of the exogenous part in presence of endogenous production. The present findings theoretically elucidate several pharmacokinetic issues for the considered drug compounds and provide guidance for the rational estimation of their pharmacokinetic parameters.
引用
收藏
页码:693 / 705
页数:13
相关论文
共 34 条
[1]  
[Anonymous], 2012, HLTH CANADA GUIDANCE
[2]   Analysis of a system of linear delay differential equations [J].
Asl, FM ;
Ulsoy, AG .
JOURNAL OF DYNAMIC SYSTEMS MEASUREMENT AND CONTROL-TRANSACTIONS OF THE ASME, 2003, 125 (02) :215-223
[3]   A mathematical analysis of rebound in a target-mediated drug disposition model: I.Without feedback [J].
Aston, Philip J. ;
Derks, Gianne ;
Agoram, Balaji M. ;
van der Graaf, Piet H. .
JOURNAL OF MATHEMATICAL BIOLOGY, 2014, 68 (06) :1453-1478
[4]   COMPUTATION OF THE EXPLICIT SOLUTION TO THE MICHAELIS-MENTEN EQUATION [J].
BEAL, SL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1983, 11 (06) :641-657
[5]   ON THE SOLUTION TO THE MICHAELIS-MENTEN EQUATION [J].
BEAL, SL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (01) :109-119
[6]   On the Lambert W function [J].
Corless, RM ;
Gonnet, GH ;
Hare, DEG ;
Jeffrey, DJ ;
Knuth, DE .
ADVANCES IN COMPUTATIONAL MATHEMATICS, 1996, 5 (04) :329-359
[7]   Neutrophil dynamics during concurrent chemotherapy and G-CSF administration: Mathematical modelling guides dose optimisation to minimise neutropenia [J].
Craig, Morgan ;
Humphries, Antony R. ;
Nekka, Fahima ;
Belair, Jacques ;
Li, Jun ;
Mackey, Michael C. .
JOURNAL OF THEORETICAL BIOLOGY, 2015, 385 :77-89
[8]   Transit and lifespan in neutrophil production: implications for drug intervention [J].
De Souza, Daniel Camara ;
Craig, Morgan ;
Cassidy, Tyler ;
Li, Jun ;
Nekka, Fahima ;
Belair, Jacques ;
Humphries, Antony R. .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (01) :59-77
[9]   Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: Concepts and perspectives [J].
Derendorf, H ;
Meibohm, B .
PHARMACEUTICAL RESEARCH, 1999, 16 (02) :176-185
[10]   Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies [J].
Dostalek, Miroslav ;
Gardner, Iain ;
Gurbaxani, Brian M. ;
Rose, Rachel H. ;
Chetty, Manoranjenni .
CLINICAL PHARMACOKINETICS, 2013, 52 (02) :83-124